Companies / Santa Cruz Biotechnology / p-p38 MAPK (D-8) FITC
Santa Cruz Biotechnology

p-p38 MAPK (D-8) FITC | Santa Cruz Biotechnology

mouse monoclonal IgM; p-p38 MAPK Antibody (D-8) is an IgM κ mouse monoclonal p-p38 MAPK antibody that detects Tyr 182 phosphorylated p38 alpha MAPK14, p38 beta MAPK11 and p38 gamma MAPK12 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. p-p38 MAPK Antibody (D-8) is available as both conjugated and non-conjugated anti-p-p38 MAPK antibody forms. MAP (mitogen-activated protein) kinases play a significant role in many biological processes, including cell adhesion and spreading, cell differentiation and apoptosis. p38 alpha MAPK14, p38 beta MAPK11 and p38 gamma MAPK12 each contain one protein kinase domain and belong to the MAP kinase family. Expressed in different areas throughout the body with common expression patterns in heart, p38 proteins use magnesium as a cofactor to catalyze the ATP-dependent phosphorylation of target proteins. Via their catalytic activity, p38 alpha MAPK14, p38 beta MAPK11 and p38 gamma MAPK12 are involved in a variety of events throughout the cell, including signal transduction pathways, cytokine production and cell proliferation and differentiation. The p38 proteins are subject to phosphoryation on Thr and Tyr residues, an event which is thought to activate the phosphorylated protein.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.